MktsMarkets

Amgen Inc.
NASDAQ: AMGNKey statistics
AMGN News
Stories mentioning AMGN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 8,618,000 | 9,866,000 | 9,557,000 | 9,179,000 | 8,149,000 | 9,086,000 | 8,503,000 | 8,388,000 |
| Cost of Goods Sold | 2,744,000 | 2,976,000 | 3,082,000 | 3,011,000 | 2,968,000 | 3,112,000 | 3,310,000 | 3,236,000 |
| Gross Profit | 5,874,000 | 6,890,000 | 6,475,000 | 6,168,000 | 5,181,000 | 5,974,000 | 5,193,000 | 5,152,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 1,602,000 | 1,952,000 | 1,720,000 | 1,691,000 | 1,687,000 | 1,878,000 | 1,625,000 | 1,785,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 2,666,000 | 2,720,000 | 2,526,000 | 2,656,000 | 1,178,000 | 2,311,000 | 2,047,000 | 1,909,000 |
| Interest Income | 101,000 | 97,000 | 99,000 | 86,000 | 126,000 | 116,000 | 126,000 | 115,000 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 2,084,000 | 1,973,000 | ||||||
| Tax Provision | 265,000 | 181,000 | 705,000 | 136,000 | 243,000 | 155,000 | 271,000 | 48,000 |
| Net Income (Loss) | 1,819,000 | 1,333,000 | 3,216,000 | 1,432,000 | 1,730,000 | 627,000 | 2,830,000 | 746,000 |
| Earnings Per Share (Basic) | 3.37 | 2.48 | 5.98 | 2.66 | 3.22 | 1.17 | 5.27 | 1.39 |
| Earnings Per Share (Diluted) | 3.34 | 2.46 | 5.93 | 2.65 | 3.20 | 1.16 | 5.22 | 1.38 |
| Weighted Average Shares Outstanding (Basic) | 540,000 | 538,000 | 538,000 | 538,000 | 538,000 | 537,000 | 537,000 | 537,000 |
| Weighted Average Shares Outstanding (Diluted) | 544,000 | 542,000 | 542,000 | 541,000 | 541,000 | 541,000 | 542,000 | 541,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AMGN
Amgen Inc. (NASDAQ: AMGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol AMGN. It last traded at $435.64 (Nov 20, 2026, 4:00 PM ET), down 0.7% on the day. That gives Amgen a market capitalisation of $240.1B and a price-to-earnings ratio of 25.6.
Over the past 52 weeks AMGN has traded between $312.39 and $483.99.
Revenue for the quarter ended Mar 31, 2026 was $8.6B; net income $1.8B. Revenue was up 5.8% from $8.1B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $8.6B | $1.8B | 21.1% |
| Dec 31, 2025 | $9.9B | $1.3B | 13.5% |
| Sep 30, 2025 | $9.6B | $3.2B | 33.7% |
| Jun 30, 2025 | $9.2B | $1.4B | 15.6% |
From Amgen’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…